Home › Hidradenitis Suppurativa › Connecticut
Hidradenitis Suppurativa clinical trials in Connecticut
3 studies for Hidradenitis Suppurativa are looking for participants at sites in Connecticut.
Cities in Connecticut
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Uconn Health, Farmington
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Nov 13, 2026 · NCT07213973Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US144, Farmington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06855498ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Cromwell
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Oct 29, 2026 · NCT07783542From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.